Stock·NYSE·Financial Services
State Street Corporation (STT)
- Market cap
- $45.52B
- P/E
- 13.69
- Dividend yield
- 2.08%
- Street target
- $200.00median of 17 analysts
- 52-week range
- $111.63 $195.93
The short version
Where STT stands today, in four lines, and what CleaRank Financial AI makes of it.
STT at a glance
State Street Corporation (STT): Buy, 64/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($157.06 and $183.97).
- Earnings STT beat estimates in 8 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $34.5M and bought $312K over the last 18 months.
- Valuation P/E of 13.7 against 16.5 for the Financial Services sector: broadly in line with peers (-17%).
Figures as of October 18, 2026.
CleaRank Financial AI
CleaRank rates State Street Corporation (STT) Buy, with a model score of 64/100.
The analysts' outlook lifts the score most: 10 of 17 analysts rate it a buy and the median target is 20.7% above the price. Momentum holds it back most: the 14-day RSI of 23.2 is in the oversold zone and the MACD line is negative. The trend is mixed: STT trades 9.92% below its 50-day average of $183.97 and 5.51% above its 200-day average of $157.06. Over the past year the price rose 46.72%.
Only on CleaRank
Figures we compute ourselves from STT's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $165.72 is 9.9% below the 50-day simple moving average of $183.97.Price above its 200-day average ›
The price is 5.5% above the 200-day simple moving average of $157.06.50-day average above the 200-day ›
The 50-day average ($183.97) is 17.1% above the 200-day average ($157.06), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 64% of its 52-week range, between $111.63 and $195.93.
STT share price
Pick a period: each tab shows how far STT has moved over it, to the last close.
Today's trading
Where STT sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 13.69 is 17.0% below the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 2.97 is 21.8% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $3.4B on revenue of $15.5B, a net margin of 22.3%.Beat estimates in most recent reports ›
STT beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 2.08%, or $3.44 a share a year.
Key statistics
The headline figures for STT.
As of October 18, 2026, STT trades at $165.72, with a market value of $45.52B, a P/E ratio of 13.69 and a dividend yield of 2.08%.
What the numbers say
CleaRank Financial AI's reading of STT's valuation, growth and risks.
On earnings, State Street Corporation (STT) is valued at 13.69 times, against a median of 16.5 for Financial Services: broadly in line with peers, with the P/E 17.0% below that median. Measured against sales, the P/S of 2.97 is 21.8% below the sector median of 3.8.
Revenue grew 13.30% over the latest year, which is 1.6 percentage points ahead of the 11.7% median for Financial Services. Profitability shows a net margin of 23.78% and an operating margin of 34.63%. It generates a return on equity of 13.08%, below the sector median of 13.8%. It also reports debt-to-equity of 0.01 and a trailing dividend yield of 2.08% ($3.44 a share a year).
STT's latest earnings report, released on October 14, 2026, delivered EPS of $3.69. Analysts had expected $3.68, so the company cleared that estimate by 0.27%. In the first session after the report, the share price moved up 0.43%.
STT has beaten the EPS estimate in all 8 of its recent reports, but beats have not guaranteed gains: the stock fell the next day after 3 of them. Looking ahead, analysts expect EPS of $13.74 this fiscal year (growth of 33.4%) and $15.47 the year after (growth of 12.6%).
Day-to-day volatility is the first thing to plan around: STT has moved 1.14% on an average session. The price is 15.42% below its 52-week high of $195.93.
STT against the Financial Services sector
How STT compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-17% difference), suggesting fair market pricing relative to industry standards.
Return vs XLF: Since May 6, 2025, STT has gained 82.6% against a gain of 12.9% for XLF.
Performance against XLF
STT and the Financial Services sector fund over the same days.
Revenue and earnings
How much STT sells, and how much of it becomes profit.
Revenue growth: Revenue grew 8.1% in FY2025 to $14.0B, from $12.9B a year earlier.
Profit margin: The net margin was 21.1% in FY2025, up from 20.8% the year before.
Profitable: STT earned $2.9B in FY2025.
Earnings reality check
Did STT beat what analysts expected, and how did the stock react?
Earnings record: STT beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 14, 2026after close | $3.68 | $3.69 | +0.27% | +0.43% | - |
| Jul 16, 2026after close | $3.34 | $3.65 | +9.28% | -1.70% | -0.78% |
| Apr 17, 2026after close | $2.64 | $2.84 | +7.58% | +3.27% | +3.65% |
| Jan 16, 2026after close | $2.84 | $2.97 | +4.58% | -2.12% | -0.34% |
| Oct 17, 2025after close | $2.65 | $2.78 | +4.91% | +3.52% | +4.27% |
| Jul 15, 2025after close | $2.36 | $2.53 | +7.20% | +2.96% | +7.55% |
| Apr 17, 2025after close | $2.01 | $2.04 | +1.49% | -0.78% | +7.53% |
| Jan 17, 2025after close | $2.44 | $2.60 | +6.56% | +1.40% | +2.67% |
As of October 18, 2026, STT has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on October 14, 2026, came in 0.27% above the estimate and the stock moved +0.43% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 23.2, in oversold territory.RSI above 50 ›
An RSI of 23.2 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of STT
The score, the reasoning behind it, and what could move the price next.
State Street Corporation (STT) is caught between its two moving averages. At $165.72, the stock trades 5.51% above its 200-day average of $157.06, yet it sits 9.92% below its 50-day average of $183.97. Across its 52-week range, running from $111.63 to $195.93, the price stands at 64%.
Momentum is weak right now. The 14-day RSI sits at 23.2, which is in the oversold zone, and the MACD line is negative. Still, the longer record is firmer than the latest pullback: over the past three months the price fell 9.19%, and over the past month it fell 9.39%, yet over the past year it rose 46.72%. In the last session the price fell 1.12% on volume that was 33.9% above its average.
Earnings beat ›
The October 14, 2026 report beat the EPS estimate by 0.27%, and the share price rose 0.43% in the first session after it.
Source: Earnings report, October 14, 2026
Rating reaffirmed ›
TD Cowen kept its Buy rating on October 8, 2026.
Source: Analyst action, TD Cowen, October 8, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $175.35 sits above the price, and the 200-day SMA at $157.06 sits below it.
- The 14-day RSI reads 23.2, in the oversold zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- STT's share price rose 0.43% in the first session after the October 14, 2026 report, and the company has beaten estimates in 8 of the last 8 reports.
The trend is mixed: STT is above its 200-day average at $157.06 but below its 50-day average at $183.97. A close above the 50-day would turn both signals up, and a close below the 200-day would turn both down. In the meantime the price sits between the 200-day SMA ($157.06) underneath and the 20-day EMA ($175.35) overhead.
The RSI is in oversold territory, so a recovery back above the oversold line would be the first hint that selling pressure is fading.
Technical indicators
Momentum and trend for STT, from its daily closes.
As of October 18, 2026, with STT at $165.72, its 14-day RSI is 23.2 (oversold territory), its 50-day simple moving average is $183.97 and its 200-day is $157.06.
Calculated by CleaRank on daily closes as of October 18, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What STT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 18, 2026, STT's 1-year correlation of daily returns is +0.65 with S&P 500 (SPY), +0.55 with Nasdaq 100 (QQQ), +0.31 with Bitcoin (BTC) and +0.14 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
10 of 17 analysts rate it a buy or strong buy, 6 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $200.00 is 20.7% above the price.More buy ratings than three months ago ›
10 of 17 rate it a buy now, against 9 of 16 three months ago.
STT Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | TD Cowen | Reinstates | Buy |
| Oct 6, 2026 | Truist Securities | Maintains | Hold |
| Oct 6, 2026 | BMO Capital | Maintains | Outperform |
| Oct 5, 2026 | Citigroup | Maintains | Buy |
| Oct 2, 2026 | JP Morgan | Maintains | Neutral |
| Aug 4, 2026 | JP Morgan | Maintains | Neutral |
As of October 18, 2026, 17 Wall Street analysts cover STT: 10 rate it a buy or strong buy, 6 a hold and 1 a sell or strong sell. Their 12-month price targets range from $150.00 to $220.00, with a median of $200.00, 20.7% above the price of $165.72.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
STT trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from STT's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much STT tends to move, against the market and on its own.
The long record
STT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.14% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 55.7%, from January 2018 to March 2020, regained by January 2022.Most 1-year holds ended higher ›
64% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $31,537, against $41,793 in the S&P 500 (SPY).
STT Drawdowns & Recovery
As of October 18, 2026, STT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -55.7% (January 2018 to March 2020); it regained that peak by January 2022, 22 months after the low, and 64% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into STT in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: STT trailed the S&P 500 over this period: $31,537 against $41,793.
A $10,000 investment in STT in October 2016 would be worth about $31,537 today with dividends reinvested, compared with about $41,793 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to STT, and which have not.
Strongest month, November: an average of +8.74%, up in 9 of 10 years.
Weakest month, March: an average of -5.57%, up in 2 of 10 years.
This month, October: has averaged +3.33%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, STT's strongest calendar month has been November (average +8.74%, up in 9 of 10 years) and its weakest March (average -5.57%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in STT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in STT today could grow to about $20,422 by 2036 in the base case, with a 90th-percentile outcome near $77,011 and a 10th-percentile outcome around $5,416. The simulation models price only; at today's 2.08% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
STT Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $221 for STT by 2030 in the base case, from $166 today (1.3x over 4 years). The 10th-percentile path ends near $95.24. These are outcomes of a Monte Carlo simulation run on STT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $117 | $178 | $271 | |
| 2028 | $106 | $191 | $346 | |
| 2029 | $99.24 | $205 | $425 | |
| 2030 | $95.24 | $221 | $510 | |
| 2031 | $92.64 | $237 | $605 |
Method: a lognormal simulation of STT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
STT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $312K on the open market and sold $34.5M.
As of October 18, 2026, STT insiders reported 30 open-market sales worth $34.5M and 1 open-market purchase worth $312K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Michael L Richards
Officer
|
Grant | 1.0K | - |
| Aug 31, 2026 | Craig Jack Read
Officer
|
Grant | 9.4K | - |
| Aug 14, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 2.2K | - |
| Aug 14, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 10.5K | - |
| Aug 3, 2026 | Elizabeth Schaefer
Officer
|
Sell | 500 | $90.6K |
| Jul 24, 2026 | W Bradford Hu
Officer
|
Sell | 9.8K | $1.8M |
| Jul 21, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Sell | 14.6K | $2.7M |
| Jul 21, 2026 | Kathryn M Horgan
Officer
|
Sell | 5.5K | $1.0M |
| Jun 11, 2026 | Kathryn M Horgan
Officer
|
Sell | 5.5K | $895.3K |
| Jun 8, 2026 | Michael L Richards
Officer
|
Sell | 1.5K | $243.2K |
| May 26, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Sell | 14.6K | $2.3M |
| May 26, 2026 | W Bradford Hu
Officer
|
Sell | 9.2K | $1.4M |
| May 20, 2026 | Marie A Chandoha
Director
|
Grant | 1.5K | - |
| May 20, 2026 | Donna Demaio
Director
|
Grant | 1.5K | - |
| May 20, 2026 | Amelia C Fawcett
Director
|
Grant | 1.5K | - |
| May 20, 2026 | William C Freda
Director
|
Grant | 1.5K | - |
| May 20, 2026 | Susan M. Gordon
Director
|
Grant | 1.5K | - |
| May 20, 2026 | Patricia Halliday
Director
|
Grant | 1.5K | - |
| May 20, 2026 | S Sara Mathew
Director
|
Grant | 1.5K | - |
| May 20, 2026 | William L Meaney
Director
|
Grant | 1.5K | - |
| May 20, 2026 | Sean P. O'Sullivan
Director
|
Grant | 1.5K | - |
| May 20, 2026 | Julio A Portalatin
Director
|
Grant | 1.5K | - |
| May 20, 2026 | Brian J Porter
Director
|
Grant | 1.5K | - |
| May 20, 2026 | John B Rhea
Director
|
Grant | 2.5K | - |
| May 15, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 2.2K | - |
| May 13, 2026 | Elizabeth Schaefer
Officer
|
Sell | 500 | $75.4K |
| Apr 22, 2026 | Mostapha Tahiri
Chief Operating Officer
|
Sell | 9.6K | $1.5M |
| Apr 22, 2026 | Michael L Richards
Officer
|
Sell | 3.0K | $461.7K |
| Mar 19, 2026 | Susan M. Gordon
Director
|
Grant | 324 | - |
| Mar 11, 2026 | John Plansky
Officer
|
Sell | 16.1K | $2.0M |
| Mar 5, 2026 | Brian J Porter
Director
|
Buy | 2.5K | $312.5K |
| Mar 2, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Sell | 29.1K | $3.7M |
| Feb 26, 2026 | Joerg Ambrosius
Officer
|
Grant | 11.5K | - |
| Feb 26, 2026 | Kathryn M Horgan
Officer
|
Grant | 9.5K | - |
| Feb 26, 2026 | Yie-Hsin Hung
Officer
|
Grant | 20.2K | - |
| Feb 26, 2026 | W Bradford Hu
Officer
|
Grant | 12.3K | - |
| Feb 26, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 43.9K | - |
| Feb 26, 2026 | John Plansky
Officer
|
Grant | 12.8K | - |
| Feb 26, 2026 | Michael L Richards
Officer
|
Grant | 6.0K | - |
| Feb 26, 2026 | Elizabeth Schaefer
Officer
|
Grant | 4.2K | - |
| Feb 26, 2026 | Mark Shelton
General Counsel
|
Grant | 10.7K | - |
| Feb 26, 2026 | Mostapha Tahiri
Chief Operating Officer
|
Grant | 14.3K | - |
| Feb 26, 2026 | John F Woods
Chief Financial Officer
|
Grant | 16.1K | - |
| Feb 24, 2026 | Michael L Richards
Officer
|
Sell | 2.5K | $319.8K |
| Feb 23, 2026 | Joerg Ambrosius
Officer
|
Sell | 8.8K | $1.1M |
| Feb 23, 2026 | Kathryn M Horgan
Officer
|
Sell | 5.7K | $721.4K |
| Feb 13, 2026 | Joerg Ambrosius
Officer
|
Grant | 12.4K | - |
| Feb 13, 2026 | Kathryn M Horgan
Officer
|
Grant | 17.0K | - |
| Feb 13, 2026 | W Bradford Hu
Officer
|
Grant | 26.7K | - |
| Feb 13, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 3.5K | - |
| Feb 13, 2026 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 93.8K | - |
| Feb 13, 2026 | John Plansky
Officer
|
Grant | 22.8K | - |
| Feb 13, 2026 | Michael L Richards
Officer
|
Grant | 11.1K | - |
| Feb 13, 2026 | Mostapha Tahiri
Chief Operating Officer
|
Grant | 10.2K | - |
| Nov 28, 2025 | Kathryn M Horgan
Officer
|
Sell | 5.7K | $672.9K |
| Nov 14, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 3.5K | - |
| Nov 11, 2025 | Yie-Hsin Hung
Officer
|
Grant | 6.0K | - |
| Oct 27, 2025 | Michael L Richards
Officer
|
Sell | 1.5K | $175.9K |
| Sep 15, 2025 | Brian J Porter
Director
|
Grant | 1.4K | - |
| Aug 29, 2025 | John F Woods
Chief Financial Officer
|
Grant | 78.1K | - |
| Aug 28, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 17.4K | - |
| Aug 26, 2025 | Michael L Richards
Officer
|
Sell | 1.0K | $115.2K |
| Aug 21, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Sell | 13.3K | $1.5M |
| Aug 19, 2025 | Elizabeth Schaefer
Officer
|
Sell | 1.6K | $175.0K |
| Aug 15, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 3.5K | - |
| Aug 12, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Sell | 41.2K | $4.6M |
| Aug 11, 2025 | Yie-Hsin Hung
Officer
|
Grant | 1.7K | - |
| Aug 6, 2025 | Marie A Chandoha
Director
|
Grant | 5.5K | - |
| Jul 22, 2025 | Michael L Richards
Officer
|
Sell | 990 | $108.2K |
| May 30, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Sell | 41.2K | $4.0M |
| May 30, 2025 | Kathryn M Horgan
Officer
|
Sell | 11.1K | $1.1M |
| May 15, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 3.5K | - |
| May 15, 2025 | Ronald P. O'Hanley
Chief Executive Officer
|
Grant | 10.2K | - |
| May 14, 2025 | Marie A Chandoha
Director
|
Grant | 2.4K | - |
| May 14, 2025 | Donna Demaio
Director
|
Grant | 2.4K | - |
| May 14, 2025 | Amelia C Fawcett
Director
|
Grant | 2.4K | - |
| May 14, 2025 | William C Freda
Director
|
Grant | 2.4K | - |
| May 14, 2025 | Patricia Halliday
Director
|
Grant | 2.4K | - |
| May 14, 2025 | S Sara Mathew
Director
|
Grant | 2.4K | - |
| May 14, 2025 | William L Meaney
Director
|
Grant | 2.4K | - |
| May 14, 2025 | Sean P. O'Sullivan
Director
|
Grant | 2.4K | - |
| May 14, 2025 | Julio A Portalatin
Director
|
Grant | 2.4K | - |
| May 14, 2025 | John B Rhea
Director
|
Grant | 4.0K | - |
| May 9, 2025 | Michael L Richards
Officer
|
Sell | 750 | $70.5K |
| May 6, 2025 | Elizabeth Schaefer
Officer
|
Sell | 1.3K | $117.9K |
| May 2, 2025 | Mostapha Tahiri
Chief Operating Officer
|
Sell | 4.0K | $360.7K |
| May 1, 2025 | John Plansky
Officer
|
Sell | 11.6K | $1.0M |
| May 1, 2025 | Anthony C. Bisegna
Officer
|
Sell | 3.5K | $310.6K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 18, 2026.